HomeAI · summaries
Storia in 18 fonti
RFK Jr.'s peptide push narrowly gains backing from FDA advisers despite objections from scientists | Fortune
The panel voted 8-6 despite agency scientists’ warnings that certain peptide chemicals lack evidence of safety or effectiveness.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cbc.ca
U.S. FDA panel to review 7 peptides amid growing popularity | CBC News
U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry…
- ·
aljazeera.com
US regulators to weigh controversial peptides backed by RFK Jr
FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing.
